PGF and congenital rubella syndrome: Another promising biomarker proposed for CRS status assessment is the placental growth factor (PlGF), a member of the vascular endothelial growth factor family of cytokines; this molecule has a relevant role both in CRS and in CKD alone, predicting adverse events in the course of renal impairment.